Cubist Systematic Strategies’s BioTelemetry, Inc. BEAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-9,489
| Closed | -$684K | – | 3057 |
|
|
2020
Q4 | $684K | Buy |
+9,489
| New | +$497K | 0.01% | 1603 |
|
|
2020
Q3 | – | Sell |
-13,846
| Closed | -$626K | – | 2731 |
|
|
2020
Q2 | $626K | Buy |
+13,846
| New | +$620K | 0.01% | 1469 |
|
|
2019
Q3 | – | Sell |
-17,935
| Closed | -$864K | – | 2678 |
|
|
2019
Q2 | $864K | Sell |
17,935
-12,051
| -40% | -$634K | 0.02% | 1128 |
|
|
2019
Q1 | $1.88M | Sell |
29,986
-3,085
| -9% | -$212K | 0.06% | 469 |
|
|
2018
Q4 | $1.98M | Buy |
33,071
+32,817
| +12,920% | +$1.97M | 0.09% | 285 |
|
|
2018
Q3 | $16K | Sell |
254
-400
| -61% | -$22.3K | ﹤0.01% | 1802 |
|
|
2018
Q2 | $29K | Buy |
+654
| New | +$26.1K | ﹤0.01% | 1694 |
|
|
2017
Q4 | – | Sell |
-10,200
| Closed | -$337K | – | 2246 |
|
|
2017
Q3 | $337K | Buy |
+10,200
| New | +$353K | 0.02% | 1081 |
|
|
2015
Q4 | – | Sell |
-49,411
| Closed | -$605K | – | 2170 |
|
|
2015
Q3 | $605K | Buy |
+49,411
| New | +$630K | 0.03% | 843 |
|
|
2015
Q2 | – | Sell |
-11,632
| Closed | -$103K | – | 2278 |
|
|
2015
Q1 | $103K | Sell |
11,632
-11,311
| -49% | -$114K | 0.01% | 1660 |
|
|
2014
Q4 | $230K | Buy |
+22,943
| New | +$197K | 0.01% | 1417 |
|
|
2014
Q3 | – | Sell |
-10,367
| Closed | -$74K | – | 2029 |
|
|
2014
Q2 | $74K | Buy |
+10,367
| New | +$82.5K | ﹤0.01% | 1368 |
|
Other funds holding BEAT
Cubist Systematic Strategies's BEAT Position: Q1 2021 in Review
Cubist Systematic Strategies sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 9,489 shares — an estimated $684K sold.
Cubist Systematic Strategies first reported a position in BEAT in Q2 2014 and held it in 12 quarters. The position peaked at $1.98M in Q4 2018. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.
- Cubist Systematic Strategies reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
- Cubist Systematic Strategies sold 9,489 BioTelemetry, Inc. shares in Q1 2021, an estimated $684K.
- Cubist Systematic Strategies first reported a position in BioTelemetry, Inc. in Q2 2014 and held it in 12 quarters.
- Cubist Systematic Strategies's BioTelemetry, Inc. position peaked at $1.98M in Q4 2018.
- 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.
Based on Cubist Systematic Strategies's 13F filing for Q1 2021, filed 17 May 2021.